David R. Taft
Professor
Pharmaceutics
Long Island University
United States of America
Biography
David R. Taft is Professor of Pharmaceutics of the Arnold & Marie Schwartz College of Pharmacy and Health Sciences of Long Island University (LIU Pharmacy). He received his undergraduate degree in Pharmacy from the University of Rhode Island and his Ph.D. in Pharmaceutical Science from the University of Connecticut. He joined the faculty of Long Island University after completing a post-doctoral fellowship at the University of North Carolina School of Pharmacy. Professor Taft has served on the faculty of LIU Pharmacy for over two decades. His research interests are in the area of pharmacokinetics with a focus on drug disposition mechanisms, and he has collaborated with numerous pharmaceutical companies on preclinical evaluation of novel therapeutic entities. He has published more than 100 manuscripts, research abstracts and book chapters, and he co-edited two books. He serves on the editorial advisory boards of Journal of Pharmaceutical Sciences and Drug Development and Industrial Pharmacy. Dr. Taft is a past recipient of the American Association of Pharmaceutical Scientists (AAPS) New Investigator Grant in Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, and the University of Connecticut School of Pharmacy Distinguished Alumnus Award.
Research Interest
Pharmacokinetics and Drug Disposition; Pharmaceutics
Publications
-
Determination of Intestinal Permeability of Rigosertib (ON 01910.Na, Estybonâ„¢): Correlation with Systemic Exposureâ€, Journal of Pharmacy and Pharmacology,2013
-
Phase 1 Study of Intravenous Rigosertib (ON 01910.Na), a Novel Benzyl Styryl Sulfone Structure Producing G2/M Arrest and Apoptosis, in Adult Patients with Advanced Cancerâ€, American Journal of Cancer Research, 2013
-
Phase I Clinical Trial of Oral Rigosertib in Patients with Myelodysplastic Syndrome.â€, British Journal of Haematology,2013